Jazz Pharmaceuticals reports executive retirement
- Samantha Pearce to retire as Chief Commercial Officer by June 30, 2027
- Company to start search for her successor
- Pearce notified of retirement intent on October 6, 2026
Every EDGAR filing for Jazz Pharmaceuticals plc (JAZZ), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 5 · 10-Q expected ~Nov 5 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($1.9M).
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Renee D Gala, reporting
Anne ORiordan, reporting
Renee D Gala, reporting
Bruce C Cozadd
Bruce C Cozadd, planned sale of JAZZ shares
Bruce C Cozadd
Neena M Patil, insider filing for JAZZ
Neena M Patil, reporting
Renee D Gala, insider filing for JAZZ
Renee D Gala, reporting
Neena M Patil, planned sale of JAZZ shares
Neena M Patil, reporting
Renee D Gala, planned sale of JAZZ shares
Renee D Gala, reporting
Mary Elizabeth Henderson, planned sale of JAZZ shares
Mary Elizabeth Henderson, reporting
Mary Elizabeth Henderson, insider filing for JAZZ
Mary Elizabeth Henderson, reporting
Jennifer E. Cook, planned sale of JAZZ shares
Jennifer E. Cook, reporting
Bruce C Cozadd, planned sale of JAZZ shares
Bruce C Cozadd, reporting
Robert Iannone, insider filing for JAZZ
Robert Iannone, reporting
Ted W Love, planned sale of JAZZ shares
Ted W Love, reporting
Robert Iannone, planned sale of JAZZ shares
Robert Iannone, reporting
Samantha Pearce, insider filing for JAZZ
Samantha Pearce, reporting